Actively Recruiting
Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients With Hemiplegic Shoulder Pain.
Led by Abant Izzet Baysal University · Updated on 2025-02-27
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to compare the effectiveness of two methods of suprascapular nerve block treatment for patients experiencing hemiplegic shoulder pain, a common complication after stroke. Hemiplegic shoulder pain significantly affects rehabilitation, and the suprascapular nerve plays a major role in shoulder sensation. The study focuses on patients who have had shoulder pain for at least three months following a stroke and evaluates which nerve block method may better manage this pain. The study involves two groups of patients with post-stroke hemiplegic shoulder pain. One group receives an ultrasound-guided suprascapular nerve block, where a specific solution is injected near the nerve under ultrasound imaging to guide placement. The other group receives the nerve block based on anatomical landmarks without ultrasound. Both groups receive injections while sitting with their arm by their side, using a mixture of lidocaine, betamethasone, and saline. The study is randomized and includes 50 patients divided equally by age and sex. Participants are assessed before treatment and then at 1 week, 1 month, and 3 months after the injection. Evaluations include shoulder joint range of motion, pain level using the Visual Analogue Scale, stroke recovery stages, daily living activities, muscle tone, and depression inventory. Researchers collect demographic and medical history data at the start. The goal is to measure improvements in shoulder function and pain relief over time, with safety monitored throughout the study period.
CONDITIONS
Brief Title
Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hemiplegic shoulder pain lasting for at least 3 months
- Visual analogue scale score greater than 3 during passive shoulder joint movement on the hemiplegic side
- Age between 25 and 75 years
- Diagnosis of post-stroke hemiplegia
- Receiving routine conservative rehabilitation treatment at a physical therapy clinic
You will not qualify if you...
- Mini mental test score less than 24
- Uncontrolled diabetes
- Coagulopathy or blood clotting disorders
- Botulinum toxin administration in the past six months
- Any injection in the shoulder region in the last six months
- Hypersensitivity to injection agents
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment visit
Participants receive either ultrasound-guided or anatomical landmark-guided suprascapular nerve block injection for hemiplegic shoulder pain.
1 injection visit (in-person)
Duration - 3 months
Participants are evaluated for shoulder joint range of motion, pain level, stroke recovery stages, functional independence, muscle tone, and mood before treatment and at 1 week, 1 month, and 3 months after the injection.
4 visits (in-person) including baseline, 1 week, 1 month, and 3 months post-injection
Trial Site Locations
Total: 1 location
1
Abant Izzet Baysal University
Bolu, Turkey (Türkiye), 14100
Actively Recruiting
Research Team
S
Serdar Kılınç
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here